Filter posts

“Diverse Candidates Can Win If They Can Get the Interview.”

Diversity is gaining more attention among biotech investors and companies alike. At entry level, 50% …

#BIF17: Looking Ahead to 2018 Policy Landscape

The past year has seen a number of important changes in the legislative and policy …

A Discussion on Value at #BIF17

In a recent op-ed, BIO President and CEO Jim Greenwood wrote about a promising trend …

“Invest in What’s Cool. Invest in Science that Matters.”

One reality of the biotech industry that’s often overlooked is that 90% of biotech companies …

#BIF17: Turning the Tide on Antimicrobial Resistance

It’s no secret that antimicrobial resistance (AMR) is one of the most serious public health …

BIO Investor Forum Opens Amid Positive Signs for Emerging Biotechs

Today the BIO Investor Forum opens in San Francisco amid optimism in the biotech sector. …

Partnering is Key to Success at 2017 BIO Investor Forum

The 2017 BIO Investor Forum is less than a month away, and BIO’s One-on-One Partnering™ …

Exploring the Richness of Companies and Investors at the BIO Investor Forum

The 16th Annual BIO Investor Forum, taking place October 17th-18th in San Francisco, is the …

Emerging Biotechs Show Their Stuff at the BIO Investor Forum in San Francisco Oct. 17-18

The next medical breakthrough is most likely under development right now in an early-stage biotech …

Vote for the Next Buzz of BIO at the BIO Investor Forum

Cast your vote for the next Buzz of BIO at the BIO Investor Forum! Vote …